JP2020519669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519669A5 JP2020519669A5 JP2019563191A JP2019563191A JP2020519669A5 JP 2020519669 A5 JP2020519669 A5 JP 2020519669A5 JP 2019563191 A JP2019563191 A JP 2019563191A JP 2019563191 A JP2019563191 A JP 2019563191A JP 2020519669 A5 JP2020519669 A5 JP 2020519669A5
- Authority
- JP
- Japan
- Prior art keywords
- pellet according
- ethyl cellulose
- weight
- release coating
- hpmc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023073242A JP7499539B2 (ja) | 2017-05-17 | 2023-04-27 | ホモタウリンおよびその塩の製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762507532P | 2017-05-17 | 2017-05-17 | |
| US62/507,532 | 2017-05-17 | ||
| US201862660690P | 2018-04-20 | 2018-04-20 | |
| US62/660,690 | 2018-04-20 | ||
| PCT/US2018/033205 WO2018213589A1 (en) | 2017-05-17 | 2018-05-17 | Formulations of homotaurines and salts thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023073242A Division JP7499539B2 (ja) | 2017-05-17 | 2023-04-27 | ホモタウリンおよびその塩の製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519669A JP2020519669A (ja) | 2020-07-02 |
| JP2020519669A5 true JP2020519669A5 (https=) | 2021-07-26 |
Family
ID=64274653
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563191A Pending JP2020519669A (ja) | 2017-05-17 | 2018-05-17 | ホモタウリンおよびその塩の製剤 |
| JP2023073242A Active JP7499539B2 (ja) | 2017-05-17 | 2023-04-27 | ホモタウリンおよびその塩の製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023073242A Active JP7499539B2 (ja) | 2017-05-17 | 2023-04-27 | ホモタウリンおよびその塩の製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12042566B2 (https=) |
| EP (1) | EP3624788A4 (https=) |
| JP (2) | JP2020519669A (https=) |
| KR (1) | KR20200005576A (https=) |
| AU (2) | AU2018269557B2 (https=) |
| IL (1) | IL270654B2 (https=) |
| WO (1) | WO2018213589A1 (https=) |
| ZA (1) | ZA201908264B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL270654B2 (en) | 2017-05-17 | 2024-07-01 | Confluence Pharmaceuticals Llc | Formulations of homotaurines and salts thereof |
| WO2025163673A1 (en) * | 2024-01-29 | 2025-08-07 | Micro Labs Limited | Dose-dumping resistant tablets of acamprosate calcium |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01280192A (ja) | 1988-10-25 | 1989-11-10 | Nichibei Co Ltd | ブラインド内装サッシ |
| IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| PE57198A1 (es) | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
| US6514530B2 (en) * | 1997-09-09 | 2003-02-04 | Alza Corporation | Dosage form comprising means for changing drug delivery shape |
| FR2775188B1 (fr) * | 1998-02-23 | 2001-03-09 | Lipha | Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption |
| DE1073432T1 (de) | 1998-04-14 | 2002-02-07 | The General Hospital Corp., Boston | Verwendung von glycinrezeptoragonisten und glycinaufnahmeinhibitoren zur behandlung neuropsychiatrischer beschwerden |
| WO2000018374A1 (en) | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Controlled release nanoparticulate compositions |
| ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20050042277A1 (en) | 2003-07-17 | 2005-02-24 | Irukulla Srinivas | Pharmaceutical compositions having a swellable coating |
| DE102004023069A1 (de) | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
| CA2504471A1 (en) * | 2004-06-18 | 2005-12-18 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| DE102007009243A1 (de) | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets |
| JP2010532331A (ja) | 2007-07-05 | 2010-10-07 | アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） | 抗痙攣医薬組成物 |
| CA2781830C (en) | 2009-02-12 | 2018-03-27 | Indiana University Research & Technology Corporation | Materials and methods for treating developmental disorders including comorbid and idiopathic autism |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US9195775B2 (en) | 2009-06-26 | 2015-11-24 | Iii Holdings 2, Llc | System and method for managing and/or rendering internet multimedia content in a network |
| US20110142889A1 (en) | 2009-12-16 | 2011-06-16 | Nod Pharmaceuticals, Inc. | Compositions and methods for oral drug delivery |
| MX346203B (es) * | 2010-09-28 | 2017-03-09 | Depomed Inc | Formas de dosificacion retentivas gastricas para liberacion prolongada de acamprosato en el tracto gastrointestinal superior. |
| TR201809351T4 (tr) | 2011-03-01 | 2018-07-23 | Pharnext | Nörolojik bozuklukların baklofen ve akamprosat tabanlı terapisi. |
| DK3272342T3 (da) | 2011-03-23 | 2021-06-07 | Ironshore Pharmaceuticals & Dev Inc | Fremgangsmåder og sammensætninger til behandling af opmærksomhedsforstyrrelse |
| JP5893135B2 (ja) | 2011-06-28 | 2016-03-23 | ビボゾーン インコーポレイテッド | 多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途 |
| US20130143867A1 (en) * | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| AU2013293167B2 (en) | 2012-07-22 | 2019-04-18 | Indiana University Research And Technology Corporation | Modulation sAPP, sAPP alpha and BDNF levels in individuals diagnosed with FXS and ASD |
| US20140073678A1 (en) | 2012-09-12 | 2014-03-13 | Monosol Rx, Llc | Anti-pain and anti-nausea and/or vomiting combinatorial compositions |
| WO2014197744A1 (en) | 2013-06-05 | 2014-12-11 | Synchroneuron, Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| AU2015217796B2 (en) | 2014-02-11 | 2020-04-30 | Pharnext | Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders |
| SG11201708393UA (en) * | 2015-05-04 | 2017-11-29 | Confluence Pharmaceuticals Llc | Sprinkle formulations of acamprosate |
| HK1255584A1 (zh) | 2015-08-04 | 2019-08-23 | Confluence Pharmaceuticals, Llc | 使用阿坎酸及d-环丝胺酸的联合疗法 |
| JP6066009B1 (ja) | 2016-06-16 | 2017-01-25 | 富士電機株式会社 | ガス絶縁開閉装置用操作器及びそれを用いたガス絶縁開閉装置 |
| IL270654B2 (en) | 2017-05-17 | 2024-07-01 | Confluence Pharmaceuticals Llc | Formulations of homotaurines and salts thereof |
-
2018
- 2018-05-17 IL IL270654A patent/IL270654B2/en unknown
- 2018-05-17 EP EP18802495.4A patent/EP3624788A4/en active Pending
- 2018-05-17 US US16/612,877 patent/US12042566B2/en active Active
- 2018-05-17 JP JP2019563191A patent/JP2020519669A/ja active Pending
- 2018-05-17 KR KR1020197035170A patent/KR20200005576A/ko not_active Ceased
- 2018-05-17 AU AU2018269557A patent/AU2018269557B2/en active Active
- 2018-05-17 WO PCT/US2018/033205 patent/WO2018213589A1/en not_active Ceased
-
2019
- 2019-12-11 ZA ZA2019/08264A patent/ZA201908264B/en unknown
-
2021
- 2021-08-31 AU AU2021225172A patent/AU2021225172B2/en active Active
-
2023
- 2023-04-27 JP JP2023073242A patent/JP7499539B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019147832A5 (https=) | ||
| JP2009502487A5 (https=) | ||
| JP2009545560A5 (https=) | ||
| JP2009502969A5 (https=) | ||
| JP2012236837A5 (https=) | ||
| JP2010511663A5 (https=) | ||
| KR20110081316A (ko) | 디아세레인 함유 약제학적 조성물 | |
| JP2012153724A5 (https=) | ||
| JP2014523445A5 (https=) | ||
| JP2019513800A5 (https=) | ||
| RU2014101227A (ru) | Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм | |
| CN103784414B (zh) | 一种埃索美拉唑肠溶片及其制备方法 | |
| JP2009537611A5 (ja) | リポ酸のペレット | |
| US20090004284A1 (en) | Controlled release tamsulosin hydrochloride formulation | |
| US20140178468A1 (en) | Multiparticulate extended-release composition of mesalamine | |
| US20110052687A1 (en) | Extended release pharmaceutical composition of paliperidone | |
| RU2018137359A (ru) | Пероральные фармацевтические композиции месалазина | |
| JP2020519669A5 (https=) | ||
| RU2008136766A (ru) | Таблетки метопролола сукцината пролонгированного действия и способы их приготовления | |
| RU2015138784A (ru) | Фармацевтическая композиция в виде мультичастиц, содержащая множество гранул двух видов | |
| CN101721385B (zh) | 一种美沙拉嗪口服控释药物组合物 | |
| WO2014060561A1 (en) | Oral pharmaceutical formulations comprising dabigatran | |
| JP2019513801A5 (https=) | ||
| US10258577B2 (en) | Multilayer solid pharmaceutical dosage forms | |
| US20100172972A1 (en) | Enteric coated pharmaceutical compositions |